Good! Liberia to Receive Trial Drug Zmapp to Treat Ebola Cases

Liberia will receive an untested experimental drug, Zmapp, to treat people infected with Ebola, the Liberian government says. The move came after a request to the US from Liberian President Ellen Johnson Sirleaf. US government officials said their role had been to put Liberian officials in contact with Zmapp maker Mapp Biopharmaceutical.

The pharmaceutical company said its supply of the drug was exhausted after its supplies were sent to West Africa. The drug was "provided at no cost in all cases," the company added.

Zmapp has been used in the US on two aid workers who have shown signs of improvement, and a Roman Catholic priest, infected with Ebola in Liberia, who is currently being treated in a hospital in Madrid.

However, the drug has only been tested on monkeys and has not yet been evaluated for safety in humans.